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Semantic empowerment of Health 
Care and Life Science Applications 
 
WWW 2006 W3C Track,  May 26 2006 
Amit Sheth  
 
LSDIS Lab           &               Semagix 
University of Georgia 
 
 
 Joint work with Athens Heart Center, and CCRC, UGA 
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Part I: A Healthcare Application 
Active Semantic Electronic Medical Record  
@ Athens Heart Center (use Firefox) 
(deployed since Dec 2005) 
 
Collaboration between LSDIS & Athens Heart Center  
(Dr. Agrawal, Dr. Wingate 
For on line demo: Google: Active Semantic Documents 
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Active Semantic Document 
A document (typically in XML) with 
• Lexical and Semantic annotations (tied to 
ontologies)  
• Active/Actionable information (rules over 
semantic annotations) 
 
Application: Active Semantic EMR for Cardiology 
Practice 
• EMRs in XML  
• 3 ontologies (OWL), populated  
• RDQL->SPARQL, Rules  
• Services, Web 2.0 
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Active Semantic Electronic Medical Record 
Demonstrates use of Semantic Web technologies to  
• reduce medical errors and patient safety  
– accurate completion of patient charts (by checking drug 
interactions and allergy, coding of impression,…) 
• improve physician efficiency, extreme user 
friendliness, decision support  
– single window for all work; template driven sentences, 
auto-complete, contextual info., exploration 
• improve patient satisfaction in medical practice 
– Formulary check 
• improve billing due to more accurate coding and 
adherence to medical guidelines  
– Prevent errors and incomplete information that insurance 
can use to withhold payment  
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One of 3 ontologies used (part of drug 
ontology) 
 
          Drug 
Generic 
Interaction 
Formulary 
Physical Condition 
BrandName 
Indication 
Pregnancy 
has_interaction 
Non-Drug Reactant 
has_indication has_formulary 
Dosage Form Intake Route 
MonographClass Type 
CPNUMGrp 
Allergy 
has_type 
 
has_class reacts_with 
Local, licensed and public (Snomed) sources to populated ontologies 
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Example Rules 
• drug-drug interaction check,  
• drug formulary check (e.g., whether the drug is 
covered by the insurance company of the patient, 
and if not what the alternative drugs in the same 
class of drug are),  
• drug dosage range check,  
• drug-allergy interaction check,  
• ICD-9 annotations choice for the physician to 
validate and choose the best possible code for the 
treatment type, and  
• preferred drug recommendation based on drug 
and patient insurance information  
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Exploration of the neighborhood of the drug 
Tasmar 
Tasmar Telcapone 
Formulary_1498 
generic/brandname 
CPNUMGroup_2119 
belongsTo belongsTo 
interacts_with 
CPNUMGroup_2118 
interacts_with 
CPNUMGroup_20
6 
classification 
Neurological 
Agents 
COMT Inhibitors 
8 
Active Semantic Doc with 3 Ontologies 
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Explore neighborhood for drug Tasmar  
 
Explore: Drug Tasmar  
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Explore neighborhood for drug Tasmar  
 
belongs to group 
belongs to group 
brand / generic 
classification 
classification 
classification 
interaction 
Semantic browsing and querying--  perform 
decision support (how many patients are 
using this class of  drug, …) 
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Software Architecture 
 
12 
 
 
 
ROI 
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Athens Heart Center Practice Growth 
Appointments (excluding cancelled/rescheduled 
but including noshow cases)
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Increased efficiency demonstrated as more encounters supported  
without increasing clinical staff 
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Chart Completion before the preliminary 
deployment of the ASMER 
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Chart Completion after the preliminary 
deployment of the ASMER 
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Applying Semantic Technologies 
 to the Glycoproteomics Domain 
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Quick take on bioinformatics ontologies and their use 
• GlycO and ProPreO - among the largest populated ontologies 
in life sciences 
• Interesting aspects of structuring and populating these 
ontologies, and their use 
• GlycO 
– a comprehensive domain ontology; it uses simple 
‘canonical’ entities to build complex structures thereby 
avoids redundancy → ensures maintainability and 
scalability 
– Web process for entity disambiguation and common 
representational format → populated ontology from 
disparate data sources 
– Ability to display biological pathways 
• ProPreO is a comprehensive ontology for data and process 
provenance in glycoproteomics 
• Use in annotating experimental data, high throughput 
workflow 
 
 
18 
GlycO 
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• Challenge – model hundreds of thousands of 
complex carbohydrate entities 
• But, the differences between the entities are 
small (E.g. just one component) 
 
 
 
 
• How to model all the concepts but preclude 
redundancy → ensure maintainability, 
scalability 
GlycO ontology 
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N. Takahashi and K. Kato, Trends in Glycosciences 
and Glycotechnology, 15: 235-251 
β-D-GlcpNAc β-D-GlcpNAc β-D-Manp -(1-4)- -(1-4)- 
α-D-Manp -(1-6)+ β-D-GlcpNAc -(1-2)- 
α-D-Manp -(1-3)+ β-D-GlcpNAc -(1-4)- 
β-D-GlcpNAc -(1-2)+ 
GlycoTree 
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Has 
CarbBank 
ID?
IUPAC to 
LINUCS
LINUCS to 
GLYDE
Compare to 
Knowledge 
Base
Already in 
KB?
YES
NO
Semagix Freedom knowledge 
extractor
Instance 
Data
YES:
 next Instance
Insert into 
KB
NO
Ontology population workflow  
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Has 
CarbBank 
ID?
IUPAC to 
LINUCS
LINUCS to 
GLYDE
Compare to 
Knowledge 
Base
Already in 
KB?
YES
NO
Semagix Freedom knowledge 
extractor
Instance 
Data
YES:
 next Instance
Insert into 
KB
NO
[][Asn]{[(4+1)][b-D-GlcpNAc] 
  {[(4+1)][b-D-GlcpNAc] 
    {[(4+1)][b-D-Manp] 
      {[(3+1)][a-D-Manp] 
        {[(2+1)][b-D-GlcpNAc] 
        {}[(4+1)][b-D-GlcpNAc] 
      {}}[(6+1)][a-D-Manp] 
        {[(2+1)][b-D-GlcpNAc]{}}}}}} 
GlycO population 
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Has 
CarbBank 
ID?
IUPAC to 
LINUCS
LINUCS to 
GLYDE
Compare to 
Knowledge 
Base
Already in 
KB?
YES
NO
Semagix Freedom knowledge 
extractor
Instance 
Data
YES:
 next Instance
Insert into 
KB
NO
<Glycan> 
  <aglycon name="Asn"/> 
  <residue link="4" anomeric_carbon="1" anomer="b" chirality="D" monosaccharide="GlcNAc"> 
    <residue link="4" anomeric_carbon="1" anomer="b" chirality="D" monosaccharide="GlcNAc"> 
      <residue link="4" anomeric_carbon="1" anomer="b" chirality="D" monosaccharide="Man" > 
        <residue link="3" anomeric_carbon="1" anomer="a" chirality="D" monosaccharide="Man" > 
          <residue link="2" anomeric_carbon="1" anomer="b" chirality="D" monosaccharide="GlcNAc" > 
          </residue> 
          <residue link="4" anomeric_carbon="1" anomer="b" chirality="D" monosaccharide="GlcNAc" > 
          </residue> 
        </residue> 
        <residue link="6" anomeric_carbon="1" anomer="a" chirality="D" monosaccharide="Man" > 
          <residue link="2" anomeric_carbon="1" anomer="b" chirality="D" monosaccharide="GlcNAc"> 
          </residue> 
        </residue> 
      </residue> 
    </residue> 
  </residue> 
</Glycan> 
Ontology Population Workflow  
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Pathway representation in GlycO 
Pathways do not need to be 
explicitly defined in GlycO. The 
residue-, glycan-, enzyme- and 
reaction descriptions contain 
the knowledge necessary to 
infer pathways. 
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Zooming in a little … 
The N-Glycan with KEGG 
ID 00015 is the substrate to 
the reaction R05987, which 
is catalyzed by an enzyme 
of the class EC 2.4.1.145. 
 
The product of this 
reaction is the 
Glycan with KEGG 
ID 00020. 
Reaction R05987 
catalyzed by enzyme 2.4.1.145 
adds_glycosyl_residue 
N-glycan_b-D-GlcpNAc_13 
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N-Glycosylation Process (NGP) 
 
Cell Culture 
Glycoprotein Fraction 
Glycopeptides Fraction 
extract 
Separation technique I 
Glycopeptides Fraction 
n*m 
n 
Signal integration 
Data correlation 
Peptide Fraction 
Peptide Fraction 
ms data ms/ms data 
ms peaklist ms/ms peaklist 
Peptide list N-dimensional array Glycopeptide identification and quantification 
proteolysis 
Separation technique II 
PNGase 
Mass spectrometry 
Data reduction Data reduction 
Peptide identification 
binning 
n 
1 
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830.9570    194.9604    2 
    580.2985     0.3592 
    688.3214     0.2526 
    779.4759    38.4939 
    784.3607    21.7736 
   1543.7476     1.3822 
   1544.7595     2.9977 
   1562.8113    37.4790 
   1660.7776   476.5043 
 
 
parent ion m/z 
fragment ion m/z 
ms/ms peaklist data 
fragment ion 
abundance 
parent ion 
abundance 
parent ion charge 
Semantic Annotation of MS Data 
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Semantic annotation of  Scientific Data 
Annotated ms/ms peaklist data 
<ms/ms_peak_list> 
<parameter 
instrument=“micromass_QTOF_2_quadropole_time_of_flight_mass_s
pectrometer” 
       mode = “ms/ms”/> 
<parent_ion_mass>830.9570</parent_ion_mass> 
<total_abundance>194.9604</total_abundance> 
<z>2</z> 
<mass_spec_peak m/z = 580.2985 abundance = 0.3592/> 
<mass_spec_peak m/z = 688.3214 abundance = 0.2526/> 
<mass_spec_peak m/z = 779.4759 abundance = 38.4939/> 
<mass_spec_peak m/z = 784.3607 abundance = 21.7736/> 
<mass_spec_peak m/z = 1543.7476 abundance = 1.3822/> 
<mass_spec_peak m/z = 1544.7595 abundance = 2.9977/> 
<mass_spec_peak m/z = 1562.8113 abundance = 37.4790/> 
<mass_spec_peak m/z = 1660.7776 abundance = 476.5043/> 
<ms/ms_peak_list> 
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Summary, Observations, Conclusions 
• Deployed health care application that uses 
SW technologies and W3C recommendations 
with some understanding of ROI 
• New methods for integration and 
analysis/discovery in biology driven by large 
populated ontologies 
• Projects, library and resources including 
ontologies at the LSDIS lab: 
http://lsdis.cs.uga.edu, WWW2006 paper 
